• Globe Newswire

Curium Announces a Strategic Investment of Over €32 million in Saclay, France

Globenewswire -

• Globe Newswire

Curium Group, PeptiDream and PDRadiopharma Enroll First Patient to Registrational Clinical Trial of Lu-PSMA-I&T for Prostate Cancer in Japan

Globenewswire -

• Globe Newswire

Curium Establishes Legal Entity in China

Globenewswire -

• Globe Newswire

CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally

Globenewswire -

• Globe Newswire

Curium and NRG PALLAS extend collaboration in the supply of essential medical isotope to hospitals

Globenewswire -

• Globe Newswire

Curium Completes the Acquisition of Monrol as Part of its Plan to Significantly Expand Lutetium-177 Capacity and PET Footprint

Globenewswire -

• Globe Newswire

Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer